The study evaluates MRK’s pulmonary arterial hypertension (PAH) drug, Winrevair (sotatercept), for a more advanced version of the disease. This decision is based on strong efficacy data from ...

"External" causes like drug overdoses and homicide are killing young adults, but so are cardiometabolic diseases that previously mainly posed risks to older people. (Getty Creative) ...

SALT LAKE CITY — Weight loss drugs like Ozempic and Wegovy have been tied in a large, national study to a drop in the risk of developing dozens of health conditions. But the semaglutide-like ...

"Most studies provided very low certainty evidence about the outcomes of interest, thus, we cannot exclude the possibility of benefit or harm," write the study authors. "All other published ...

The study was published this week in the journal Nature Medicine. Advertisement With the drugs' novelty and soaring popularity, it's important for consumers to know about the effects on all organ ...

These drugs, initially developed for diabetes treatment, have gained popularity for aiding weight loss and addressing other health conditions. However, the findings raise important questions about ...

The study, published on Jan 20 in the journal Nature Medicine, found protective effects related to impulse control, adding to evidence that the drugs may not only suppress appetite but also help ...

The study in Nature Medicine explores the potential wider benefits and risks of diabetes drugs GLP-1 receptor agonists. Besides weight loss, these drugs might reduce risks for neurocognitive disorders ...

Published in the journal Nature Medicine, the research examined the relationship between GLP-1 weight-loss drugs and 175 diseases and conditions. AP The study was published in the the journal ...

including several newly found conditions linked to the GLP-1 class of weight loss and diabetes drugs. However, the new study led by Ziyad Al-Aly, a physician-scientist at the Veterans Affairs St.

Weight loss drugs like Ozempic and Wegovy have been tied in a large, national study to a drop in the risk of developing dozens of health conditions. But the semaglutide-like drugs also appear to ...

Now, as the companies run trials to flesh out the potential of the drugs to treat other conditions, an observational study from Washington University in St. Louis has shed more light on the ...